The slip
PARKINSON RECEIPTno. 8266
24 Oct 2026, 04:04 UTCdopamine neurons, braak
predictionCOL1A1 in dopamine neurons tracks Braak Lewy-body stage
registered447fd6f7277c3883
discovery-0.40 p=0.285 n=9
replication-0.55 p=0.128 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.40, p 0.285)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT51d02b241e0a39da1c5d738b…
follows 81ded6d2888c…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8266: COL1A1 in dopamine neurons, braak
- power
- full sample -0.50 (p 0.034, n 18), 95% CI -0.78 to -0.04. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.52 (p 0.026, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.60 (p 0.0080, n 18). not the mix.
- skeptic
- leave-one-out range -0.61 to -0.44, sign flips 0; without severely affected donors -0.50 (p 0.034, n 18). robust.
- cell type
- strongest in microglia: -0.76 (p 2.9e-4, n 18) vs -0.50 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for COL1A1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up COL1A1 · microglia · braak: substantia nigra, an independent cohort: not measured